The FERO Cancer Dr. Josep Baselga Grant 2027 offers €300,000 over up to three years to established investigators leading translational oncology research in Spain. The grant supports projects with strong existing evidence and a clear path to clinical validation or use in patient care.
The first stage requires a research proposal of no more than three pages, written in English. Only shortlisted teams will be invited to submit a full proposal.
Eligibility Criteria
- Applicants may be of any nationality and must hold an MD, a PhD or both.
- By the award date, applicants must be affiliated with an eligible nonprofit research institution in Spain. Those without a contract at the time of application must submit a signed letter from the proposed host.
- Applicants must have led an independent research programme, group or team for at least five years.
- Applicants must show a track record in translational oncology and have secured competitive funding as principal investigator for at least two projects in the past three years.
- The proposed work must be original, backed by evidence and ready to move toward clinical validation or use. The activities in the proposal cannot already be funded.
- Each applicant may submit one proposal to this call. The same project cannot be submitted to another FERO call in the same round.
Funding Details
- Award: €300,000 over up to three years. FERO plans to fund one project.
- Payment: €150,000 at project start, with the second instalment subject to a favourable interim review.
- Indirect costs: Up to 5% of eligible direct costs, excluding external services and subcontracting from the calculation.
Deadline
- Short proposal: November 13, 2026, at 3:00 p.m. CET.
- Shortlist notification: December 18, 2026
- Full proposal, by invitation: January 29, 2027, at 3:00 p.m. CET.
- Award decision: Expected in late March 2027.